Balance Sheet
Cash Flow Statement
Cash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alaunos Therapeutics (TCRT) Other financing activities (2019 - 2021)

Alaunos Therapeutics (TCRT) has disclosed Other financing activities for 2 consecutive years, with $185000.0 as the latest value for Q4 2021.

  • For the quarter ending Q4 2021, Other financing activities changed N/A year-over-year to $185000.0, compared with a TTM value of $183000.0 through Dec 2022, changed N/A, and an annual FY2021 reading of $260000.0, changed N/A over the prior year.
  • Other financing activities was $185000.0 for Q4 2021 at Alaunos Therapeutics, up from -$2000.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $185000.0 in Q4 2021 and bottomed at -$2000.0 in Q1 2019.